Hyperthyroidism
📧 Sign up to get email alerts when something new happens for Hyperthyroidism.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-06-26FDA Approved: PROPYLTHIOURACIL — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for Propylthiouracil from Macleods Pharmaceuticals Limited (ANDA208867).
-
CLINICAL_TRIALS research · 2024-06-11Clinical Trial Update: Efficacy and Safety of Catheter Ablation of Atrial Fibrillation in Patients With Thyroid Hormone Stabilization
This clinical trial is evaluating the efficacy and safety of catheter ablation for atrial fibrillation in patients stabilized on thyroid hor…
-
CLINICAL_TRIALS trial_result · 2024-05-13Clinical Trial Update: Pharmacist Role in Thyroid Disorders [NA]
This completed clinical trial evaluates the role of pharmacists in managing thyroid disorders, including hypothyroidism and hyperthyroidism.
-
CLINICAL_TRIALS research · 2024-05-06Clinical Trial Update: Insulin Resistance in Relation to Hyperthyroidism and Hypothyroidism
This ClinicalTrials.gov entry describes a study investigating insulin resistance in relation to hyperthyroidism and hypothyroidism, sponsore…
-
CLINICAL_TRIALS trial_result · 2024-03-06Clinical Trial Update: Preoperative Preparation With Lugol Solution in Patients With Graves-Basedow Disease. [Phase 4]
Phase 4 clinical trial evaluating preoperative Lugol solution in patients with Graves-Basedow disease (hyperthyroidism).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2023-09-25FDA Approved: METHIMAZOLE — Original Application (Bionpharma Inc.)
The FDA approved an original application for a generic Methimazole from Bionpharma Inc., adding a generic version of the antithyroid medicat…
-
FDA approval · 2023-05-24FDA Approved: METHIMAZOLE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved the original application for methimazole from Macleods Pharmaceuticals Limited (ANDA209827).
-
FDA approval · 2023-05-10FDA Approved: PROPYLTHIOURACIL — Original Application (Macleods Pharmaceuticals Limited)
FDA approved Macleods Pharmaceuticals Limited's original ANDA for Propylthiouracil, an antithyroid medication used to treat hyperthyroidism.
-
CLINICAL_TRIALS trial_result · 2022-08-23Clinical Trial Update: LIthium as Bridging thErapy Prior to Radioactiveiodine in hyperThYroidism [Phase 4]
A Phase 4 clinical trial evaluated lithium as a bridging therapy prior to radioactive iodine in hyperthyroidism; the study is completed.
-
CLINICAL_TRIALS trial_result · 2021-11-17Clinical Trial Update: Doxycycline Treatment in Mild Thyroid-Associated Ophthalmopathy [Phase 2]
Phase 2 clinical trial update evaluating doxycycline for mild thyroid-associated ophthalmopathy (Graves-related eye disease).
-
CLINICAL_TRIALS trial_result · 2021-11-12Clinical Trial Update: Effect of Hyperthyroidism and Its Treatment in Graves' Disease to Early Marker of Atherosclerosis [Phase 3]
Phase 3 trial update examining the effect of hyperthyroidism and its treatment on an early marker of atherosclerosis in Graves' disease.
-
FDA approval · 2021-10-20FDA Approved: METHIMAZOLE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approves a supplemental application from Rising Pharma Holdings, Inc. for a generic methimazole product, expanding access to the labeled…
-
FDA approval · 2021-10-20FDA Approved: METHIMAZOLE — Supplemental Application (Strides Pharma Science Limited)
The FDA approved a supplemental application from Strides Pharma Science Limited for methimazole, a generic antithyroid medication. The appro…
-
FDA approval · 2021-06-11FDA Approved: HICON — Supplemental Application (Jubilant DraxImage Inc., dba Jubilant Radiopharma)
FDA approved a supplemental application for HICON (Sodium I-131) from Jubilant DraxImage Inc., dba Jubilant Radiopharma.
-
FDA approval · 2021-03-18FDA Approved: PROPYLTHIOURACIL — Supplemental Application (QUAGEN PHARMACEUTICALS LLC)
FDA approved a supplemental application for Propylthiouracil from Quagen Pharmaceuticals LLC under the ANDA process.
-
CLINICAL_TRIALS research · 2020-04-13Clinical Trial Update: Bone Structure and Strength Evaluated by Extreme-CT Scan Before and After Treatment of Hyper- and Hypothyroidism
A completed clinical trial evaluating bone structure and strength using extreme-CT scans before and after treatment for hyperthyroidism and …
-
CLINICAL_TRIALS trial_result · 2020-02-13Clinical Trial Update: Thermogenesis in Hyperthyroidism and Effect of Anti-Adrenergic Therapy [Phase 4]
A Phase 4 clinical trial evaluating thermogenesis in hyperthyroidism and the effect of anti-adrenergic therapy has completed.
-
FDA approval · 2020-02-05FDA Approved: SODIUM IODIDE I-131 — Original Application (Radnostix, Inc.)
FDA approved the original application for Sodium Iodide I-131 (Radnostix, Inc.), a radiopharmaceutical used to treat hyperthyroidism and thy…
-
FDA approval · 2019-12-06FDA Approved: PROPYLTHIOURACIL — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for Propylthiouracil submitted by Actavis Pharma, Inc., reflecting an update to the product's la…
-
FDA approval · 2019-01-23FDA Approved: METHIMAZOLE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for methimazole from Rising Pharma Holdings, expanding the availability of this generic treatmen…
-
FDA approval · 2019-01-18FDA Approved: METHIMAZOLE — Supplemental Application (Strides Pharma Science Limited)
FDA approves a supplemental application for Strides Pharma Science Limited's methimazole, updating the already approved product under an AND…
-
FDA approval · 2019-01-18FDA Approved: METHIMAZOLE — Supplemental Application (NORTHSTAR RX LLC)
The FDA approved a supplemental application for methimazole submitted by NorthStar RX LLC.
-
FDA approval · 2019-01-18FDA Approved: METHIMAZOLE — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for Methimazole submitted by Chartwell RX, LLC (ANDA).
-
FDA label_change · 2019-01-18FDA Approved: METHIMAZOLE — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved a supplemental application for methimazole from Upsher-Smith Laboratories, updating the labeling for the antithyroid medica…
-
FDA approval · 2018-09-19FDA Approved: PROPYLTHIOURACIL — Supplemental Application (Endo USA, Inc.)
FDA approves a supplemental application for Propylthiouracil from Endo USA, Inc.